Pesquise e encontre o CMO / CDMO de que precisa

MERCADOS: EMA (EU), FDA (USA), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), Turkish Health Authorities

SERVIÇOS: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

USAR: Human, Veterinary

BSL (Nível de Segurança Biológica): 1, 2

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS

OEB (Faixas de Exposição Ocupacional): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MERCADOS: EMA (EU), FDA (USA), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

SERVIÇOS: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ISO, Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), World Health Organization (GMP / HACCP), MFDS/KFDA (Republic of Korea GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: COSMÉTICOS, NUTRACÊUTICOS, FDF / MEDICAMENTOS

USAR: Human, Veterinary

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (V06) Nutrients, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

MERCADOS: EMA (EU), PMDA (Japan), SFDA (Saudi Arabia), MFDS (South Korea)

REGIÃO: Europa

CONFORMIDADE: ISO, PMDA/MHLW (Japan GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: NUTRACÊUTICOS, FDF / MEDICAMENTOS, ENGENHARIA DE PARTÍCULAS

USAR: Human, Veterinary

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MERCADOS: EMA (EU), PMDA (Japan), FDA (USA), ANVISA (Brazil), Russian Health Authorities, EDE (UAE)

SERVIÇOS: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), UAE Ministry of Health & Prevention, EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

USAR: Human, Veterinary

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS

MERCADOS: EMA (EU), FDA (USA), Russian Health Authorities

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ISO, Roszdravnadzor (Russia GMP), EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: COSMÉTICOS, FDF / MEDICAMENTOS

USAR: Human, Veterinary

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system

OEB (Faixas de Exposição Ocupacional): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGIÃO: Europa

MERCADOS: FDA (USA), Health Canada (Canada), TGA (Australia)

CONFORMIDADE: FDA (cGMP), ISO, Halal Research Council, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: NUTRACÊUTICOS, FDF / MEDICAMENTOS

USAR: Human

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MERCADOS: EMA (EU), FDA (USA)

SERVIÇOS: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ISO, IFS, EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: COSMÉTICOS, NUTRACÊUTICOS, FDF / MEDICAMENTOS

USAR: Human, Veterinary

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

OEB (Faixas de Exposição Ocupacional): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MERCADOS: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)

REGIÃO: Europa

CONFORMIDADE: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: COSMÉTICOS, FDF / MEDICAMENTOS

USAR: Human, Veterinary

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

SUBSTÂNCIAS CONTROLADAS: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MERCADOS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ISO, EMA (EU GMP)

TAMANHO DO LOTE: Large, Small, Medium

USAR: Human, Veterinary

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS

MERCADOS: EMA (EU), FDA (USA)

REGIÃO: Europa

CONFORMIDADE: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

TAMANHO DO LOTE: Large, Small, Medium

CATEGORIA / PRODUTO: NUTRACÊUTICOS, SERVIÇOS, ENGENHARIA DE PARTÍCULAS

USAR: Human, Veterinary

BSL (Nível de Segurança Biológica): 1, 2

SERVIÇOS: Development services, Manufacturing services

OEB (Faixas de Exposição Ocupacional): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

SUBSTÂNCIAS CONTROLADAS: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MERCADOS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

REGIÃO: Europa

TAMANHO DO LOTE: Large, Small, Medium

USAR: Human

SERVIÇOS: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism

CONFORMIDADE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (Faixas de Exposição Ocupacional): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORIA / PRODUTO: SERVIÇOS, FDF / MEDICAMENTOS

ÁREAS DE EXPERIÊNCIA TERAPÊUTICA (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (A) Digestive tract and metabolism

MERCADOS: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities

REGIÃO: Europa

TAMANHO DO LOTE: Large

USAR: Human

BSL (Nível de Segurança Biológica): 1

SERVIÇOS: Manufacturing services, Analytical / QC services, Regulatory services, Packaging

SUBSTÂNCIAS CONTROLADAS: Lowest potential for abuse

CONFORMIDADE: ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

CATEGORIA / PRODUTO: FDF / MEDICAMENTOS

OEB (Faixas de Exposição Ocupacional): 1 / low-hazard (PDE > 10,000 µg/day)